HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE

被引:0
|
作者
Pokrovskaya, O. [1 ]
Mendeleeva, L. [1 ]
Urnova, E. [1 ]
Firsova, M. [1 ]
Nareyko, M. [1 ]
Kuzmina, L. [1 ]
Rekhtina, I. [1 ]
Tauson, I. [1 ]
Varlamova, E. [1 ]
Parovichnikova, E. [1 ]
Savchenko, V. [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PH-P514
引用
收藏
页码:S345 / S346
页数:2
相关论文
共 50 条
  • [31] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [32] HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    FERMAND, JP
    CHEVRET, S
    HENNEQUIN, C
    LEVY, Y
    GEROTA, J
    BENBUNAN, M
    SELIGMANN, M
    BROUET, JC
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (06): : 525 - 528
  • [33] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [34] Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma
    Cohen, Inbar
    Vaxman, Iuliana
    Gertz, Morie A.
    ACTA HAEMATOLOGICA, 2024,
  • [35] High dose therapy with autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal failure.
    Tummala, R
    Ballester, O
    Janssen, W
    Fields, K
    Hiemenz, J
    Goldstein, S
    Perkins, J
    Rosen, R
    Saez, R
    Elfenbein, G
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 706 - 706
  • [36] High-dose chemotherapy and autologous stem cell transplantation for breast cancer
    Baynes, RD
    Dansey, RD
    Klein, JL
    Karanes, C
    Cassells, L
    Abella, E
    Wei, WZ
    Galy, A
    Du, W
    Wood, G
    Peters, WP
    CANCER INVESTIGATION, 2000, 18 (05) : 440 - 455
  • [37] High-dose ream chemotherapy and autologous stem cell transplantation by high-dose BU/CY and salvage stem cell transplantation.
    Fetscher, S
    Waller, CF
    Finke, J
    Dolken, G
    Mertelsmann, R
    Lange, W
    BLOOD, 1996, 88 (10) : 3798 - 3798
  • [38] NICE guidance on bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem-cell transplantation
    Griffiths, Christian
    Sidhu, Raisa
    Sutcliffe, Frances
    Stevens, Andrew
    LANCET ONCOLOGY, 2014, 15 (06): : 563 - 564
  • [39] High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier
    Kentos, A
    Vekemans, M
    Van Vooren, JP
    Lambermont, M
    Liesnard, C
    Feremans, W
    Farber, CM
    BONE MARROW TRANSPLANTATION, 2002, 29 (03) : 273 - 275
  • [40] Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation
    M Lindemann
    P Schuett
    T Moritz
    H D Ottinger
    B Opalka
    S Seeber
    M R Nowrousian
    H Grosse-Wilde
    Leukemia, 2005, 19 : 490 - 492